Compare Eli Lilly And Co (LLY) vs Shopify Inc. (SHOP) Price & Performance

Eli Lilly (LLY) trades at $1,150.86, down 2.39% on the day, with a bullish technical signal from moving averages and strong fundamental performance. The company reported robust earnings beats in recent quarters, with Q1 2026 EPS of $8.55 exceeding expectations by 23%. Revenue surged to $65.18 billion in 2025, driving a net income margin of 34.99%. Recent news highlights LLY's $2.8 billion acquisition of AtaiBeckley to expand its neuroscience pipeline, signaling strategic growth in mental health treatments.

Outlook remains positive with analyst consensus price target of $1,380 implying 20% upside, supported by 73% buy ratings. Key risks include high valuation multiples (P/E 41.89) and rising debt levels, though operating cash flow growth to $16.81 billion in 2025 provides financial flexibility. Investors should monitor Q2 2026 earnings on August 5 for continued execution on weight-loss drug demand and integration of recent acquisitions.

SHOP trades at $125.88, up 1.88% today, with a bullish technical signal from moving averages. The stock shows strong revenue growth, reaching $11.56 billion in 2025, and has turned profitable with a net income margin of 10.77%. Recent news highlights its AI strategy and a Jefferies upgrade to Buy with a $160 target. Cash flow from operations improved to $2.03 billion, though valuation ratios remain elevated.

The outlook is positive, supported by analyst consensus and growth in AI-driven commerce. However, high P/E of 121.14 and competitive pressures from Amazon pose risks. Upside to the $150.08 consensus target depends on execution of AI initiatives and sustained profitability.